Sarcoma Immunotherapy: Confronting Present Hurdles and Unveiling Upcoming Opportunities-Reference-Cited by-同舟云学术

Sarcoma Immunotherapy: Confronting Present Hurdles and Unveiling Upcoming Opportunities

Published:2023-10 Issue:10 Volume:46 Page:579-588
ISSN:1016-8478
Container-title:Molecules and Cells
language:en
Short-container-title:Molecules and Cells

Author:

Jeong Sehan^ORCID,Afroz Sharmin^ORCID,Kang Donghyun^ORCID,Noh Jeonghwan^ORCID,Suh Jooyeon^ORCID,Kim June Hyuk^ORCID,You Hye Jin^ORCID,Kang Hyun Guy^ORCID,Kim Yi-Jun^ORCID,Kim Jin-Hong^ORCID

Funder

National Research Foundation of Korea

Ministry of Health and Welfare

Korea Health Industry Development Institute

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,General Medicine

Link

https://pdf.medrang.co.kr/KSMCB/2023/046/KSMCB046-10-02.pdf

Reference118 articles.

1. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study;Abramson;Lancet,2020

2. Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor-modified T cells for the immunotherapy of HER2-positive sarcoma;Ahmed;J. Clin. Oncol.,2015

3. Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression;Ahmed;Mol. Ther.,2009

4. Fc-optimized anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors;Arce Vargas;Immunity,2017

5. Immunotherapy in soft-tissue sarcoma;Ayodele;Curr. Oncol.,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies;iMeta;2024-01